This suggests that within the tumor microenvironment, persistent engagement of this pathway may further accelerate CD8+ T cell dysfunction, ultimately leading to the loss of antitumor immunity and facilitating immune evasion [46]. The gene discussed is CD8A; the disease is neoplasm.